Elbit Imaging (EMITF) 6-K Report of Foreign Private Issuer

Exhibit 99.1

It is hereby clarified that this summary is published solely for the sake of caution and in light of the Company’s intention to execute a Buy-Back plan of its (series I) notes.

Gamida Cell LTD.

	September 30, 2018			December 31, 2017
	Thousands usd
Current assets		24,697			43,622
Non current assents		3,815			1,300
Total Assets		28,512			44,922
Current liabilities		7,299			4,576
Non current liabilities		26,068			17,390
Total Liabilities		33,367			21,966
Shareholders’ equity (deficit)		(4,855	)		22,956
Total liabilities and shareholders’ equity		28,512			44,922

	Nine months ended September 30,					Three months ended September 30,
	2018		2017			2018			2017
	Thousands usd
Research and development expenses		17,169		10,715			5,132			3,374
General and administrative expenses		7,008		2,753			2,438			980
Financing income, net		6,126		(207	)		2,252			(417	)
Other comprehensive (profit) loss:		13		-			(122	)		-
Total comprehensive loss for the period		30,316		13,261			9,700			3,937